Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Uterine Cervical Dysplasia × Bupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 9 Breast Neoplasms 5 Pain 4 Rectal Neoplasms 2 Lung Neoplasms 2 Leiomyoma 2 Agnosia 2 post laminectomy syndrome 1 Uterine Cervical Dysplasia 1 Upper Abdominal Cancer Surgery 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroma 1 Neuralgia 1 Neoplasms 1 Myoma 1 Lymphedema 1 Kidney Neoplasms 1 Intestinal Diseases 1 Inflammatory Bowel Diseases 1 Ileus 1 Hot Flashes 1 Hemorrhage 1 Gynecologic Surgical Procedures 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Failed Back Surgery Syndrome 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Digestive System Diseases 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Papillomavirus Vaccines 3 Vaccines 2 human papillomavirus vaccine, L1 type 16, 18 1 TachoSil 1 Mindfulness 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Epinephrine 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02368054 2016-08-19

HSBAPCB

Helse Fonna

Phase 4 Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡